Article
13 Jan 2026
Digesting The New Dietary Guidelines With Key Takeaways For Regulated Entities
AUTHORS CONTENT
Article
09 Jan 2026
FDA Issues Key Guidance Updates For Digital Health And Wellness
Article
29 Dec 2025
FDA Releases Final Guidance On Best Practices For Bioresearch Monitoring Inspections
Article
29 Dec 2025
BIOSECURE Act Becomes Law
Article
19 Dec 2025
FDA's TEMPO Pilot Seeks To Expand Access To Chronic Disease Technologies In CMS Collaboration
Article
17 Dec 2025
Artificial Intelligence In Clinical Decision-Making: Regulatory Roadmap And Reimbursement Strategies
Article
21 Nov 2025
An Overview Of The Over-the-Counter Monograph Drug User Fee Amendments (OMUFA): Policy Areas To Watch
Article
10 Nov 2025
FDA Issues Draft Guidance With Updated Recommendations For Assessing The Need For Comparative Efficacy Studies In Biosimilar Development
Article
30 Oct 2025
Akin Intelligence Newsletter - August/September 2025
Article
29 Oct 2025
FDA Presses Forward On Patient-Focused Drug Development, Releases Final Guidance Focused On Fit-For-Purpose Clinical Outcome Assessments
Article
24 Oct 2025
FDA Names The First Nine National Priority Voucher Recipients
Article
13 Oct 2025
FDA Continues Focus On AI Fronts, Seeks Public Comment On Measuring And Evaluating AI-enabled Medical Device Performance In The Real-World
Article
29 Sep 2025
FDA's Latest On Emergency Diagnostics And A No-Frills Rescission Of The LDT Rule
Article
25 Sep 2025
FDA Puts Orange B On The Chopping Block
Article
16 Sep 2025
From Foods To Pharmaceuticals, MAHA Strategy Offers Broad Menu Of FDA Actions
Article
10 Sep 2025
FDA Continues Focus On Rare Disease Drug Development, Announces Evidence Principles
Article
29 Aug 2025
Congress Joins FDA In Focusing On Food Dye Limitations
Article
28 Aug 2025
OMUFA Reauthorization On Deck As Congress Returns From Recess
Article
26 Aug 2025
Akin Intelligence - July 2025
Article
14 Aug 2025
Citizen Petition Calls On FDA To Rethink Refined Carbs